Answer to the letter to the editor of A. Lawson McLean, et al. concerning “myelopathy disability index: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy” by Pons Carreto A et al. (Eur Spine J; 2023: doi:10.1007/s00586-022-07506

Answer to the letter to the editor of A. Lawson McLean, et al. concerning “myelopathy disability index: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy” by Pons Carreto A et al. (Eur Spine J; 2023: doi:10.1007/s00586-022-07506–2)

Published:2023-02-10 Issue:4 Volume:32 Page:1488-1489
ISSN:0940-6719
Container-title:European Spine Journal
language:en
Short-container-title:Eur Spine J

Author:

Ramírez M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00586-023-07576-w.pdf

Reference12 articles.

1. Editorial (2019). A focus on patient outcomes in cervical myelopathy. Lancet Neurol 18(7):615. https://doi.org/10.1016/S1474-4422(19)30168-1

2. Touzet AY, Bhatti A, Dohle E et al (2022) 2022 Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM). BMJ Open 12:e05765. https://doi.org/10.1136/bmjopen-2021-057650

3. Tetreault L, Kopjar B, Nouri A et al (2017). The modified Japanese orthopaedic association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy. Eur Spine J 26(1):78–84. https://doi.org/10.1007/s00586-016-4660-8

4. Davies BM, McHugh M, Elgheriani A et al (2016) Reported outcome measures in degenerative cervical myelopathy: a systematic review. PLoS ONE 11(8):e0157263

5. Singh A, Crockard HA (1999) Quantitative assessment of cervical spondylotic myopathy by a simple walking test. The Lancet 354:370–373